McKnight’s Senior Living February 16, 2024
(HealthDay News) — Patient-performed rapid antigen tests (RATs) are reliable for COVID-19, with comparable sensitivity and specificity to clinician-performed RATs, according to a study published online Feb. 14 in Microbiology Spectrum.
Mary Jane E. Vaeth, from the Baltimore Convention Center Field Hospital, and colleagues conducted a single-center study to assess the accuracy of self-performed RATs for COVID-19. The self-administered BinaxNOW RATs were compared with clinician-performed RATs and against laboratory molecular testing as the gold standard.
The researchers found that 14.9% of the 953 participants were positive for severe acute respiratory syndrome coronavirus 2 as...